Mus musculus Gene: Ube2l6 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||
InnateDB Gene | IDBG-185308.6 | ||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||
Gene Symbol | Ube2l6 | ||||||||||||
Gene Name | ubiquitin-conjugating enzyme E2L 6 | ||||||||||||
Synonyms | 2810489I21Rik; RIG-B; Ubce8; UBCH8; Ubcm8 | ||||||||||||
Species | Mus musculus | ||||||||||||
Ensembl Gene | ENSMUSG00000027078 | ||||||||||||
Encoded Proteins |
ubiquitin-conjugating enzyme E2L 6
ubiquitin-conjugating enzyme E2L 6
|
||||||||||||
Protein Structure | |||||||||||||
Useful resources | Stemformatics EHFPI ImmGen | ||||||||||||
Entrez Gene | |||||||||||||
Summary |
This gene does not have any Entrez summary - the following is the summary from its human ortholog ENSG00000156587:
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s). This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is highly similar in primary structure to the enzyme encoded by the UBE2L3 gene. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2011] |
||||||||||||
Gene Information | |||||||||||||
Type | Protein coding | ||||||||||||
Genomic Location | Chromosome 2:84798828-84810335 | ||||||||||||
Strand | Forward strand | ||||||||||||
Band | D | ||||||||||||
Transcripts |
|
||||||||||||
Interactions | |||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 37 interaction(s) predicted by orthology.
|
||||||||||||
Gene Ontology | |||||||||||||
Molecular Function |
|
||||||||||||
Biological Process |
|
||||||||||||
Cellular Component |
|
||||||||||||
Orthologs | |||||||||||||
Species
Homo sapiens
Bos taurus
|
Gene ID
Gene Order
Not yet available
|
||||||||||||
Pathways | |||||||||||||
NETPATH | |||||||||||||
REACTOME |
Cytokine Signaling in Immune system pathway
Antiviral mechanism by IFN-stimulated genes pathway
ISG15 antiviral mechanism pathway
Immune System pathway
Interferon Signaling pathway
|
||||||||||||
KEGG |
Ubiquitin mediated proteolysis pathway
Parkinson's disease pathway
|
||||||||||||
INOH | |||||||||||||
PID NCI | |||||||||||||
Pathway Predictions based on Human Orthology Data | |||||||||||||
NETPATH | |||||||||||||
REACTOME |
Antigen processing: Ubiquitination & Proteasome degradation pathway
Negative regulators of RIG-I/MDA5 signaling pathway
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways pathway
ISG15 antiviral mechanism pathway
Antiviral mechanism by IFN-stimulated genes pathway
Cytokine Signaling in Immune system pathway
Innate Immune System pathway
Interferon Signaling pathway
Adaptive Immune System pathway
Immune System pathway
Class I MHC mediated antigen processing & presentation pathway
ISG15 antiviral mechanism pathway
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways pathway
Cytokine Signaling in Immune system pathway
Immune System pathway
Antiviral mechanism by IFN-stimulated genes pathway
Negative regulators of RIG-I/MDA5 signaling pathway
Interferon Signaling pathway
Innate Immune System pathway
|
||||||||||||
KEGG |
Ubiquitin mediated proteolysis pathway
Parkinson's disease pathway
|
||||||||||||
INOH | |||||||||||||
PID NCI | |||||||||||||
Cross-References | |||||||||||||
SwissProt | |||||||||||||
TrEMBL | |||||||||||||
UniProt Splice Variant | |||||||||||||
Entrez Gene | |||||||||||||
UniGene | Mm.38261 | ||||||||||||
RefSeq | NM_019949 | ||||||||||||
OMIM | |||||||||||||
CCDS | CCDS16194 | ||||||||||||
HPRD | |||||||||||||
IMGT | |||||||||||||
MGI ID | |||||||||||||
MGI Symbol | |||||||||||||
EMBL | |||||||||||||
GenPept | |||||||||||||
RNA Seq Atlas | |||||||||||||